Partnering - Strategic Alliance model

Partnering To Accelerate Your Strategic Initiatives

To succeed in pharmaceutical development and commercialization, you need a partner who can help you:

• Manage risk across the product lifecycle
  • Offers sliding scale risk-sharing
  • Successful payment after achieving certain milestones
• Increase capacity for development and commercial operations
  • Provides lower upfront FTE cost
  • Exclusive access to proprietary resources and patient populations
• Expand financial scenarios and profit/loss relief

CrownBio's managed partnership model, supports your business initiative with resources and expertise. This emerging model typically provides a limited number of exclusive partners, risk sharing opportunities, very tight process integration, joint teams and early access to innovations resulting from Crown Biosciences scientific expertise in pre-clinical oncology.

Our model successfully creates long-term peer-to-peer relationships by leveraging a unique combination of global resources and management capabilities, scientific and drug development expertise, and offers corporate finance and investment capital for pharmaceutical product development and commercialization.

Contact our Business Development team at This e-mail address is being protected from spambots. You need JavaScript enabled to view it today to consider all your options.